Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression
Thomas Stricker, Christopher D. Brown, Chaitanya Bandlamudi, et al.
PLoS Genetics (2017) Vol. 13, Iss. 3, pp. e1006589-e1006589
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 305-320.e10
Open Access | Times Cited: 349
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1
Ling Deng, Li Liao, Yin‐Ling Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 19
A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer
Diogo F. T. Veiga, Alex Nesta, Yuqi Zhao, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 49
hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells
Ilaria Passacantilli, Paola Frisone, Elisa De Paola, et al.
Nucleic Acids Research (2017) Vol. 45, Iss. 21, pp. 12270-12284
Open Access | Times Cited: 71
The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data
Chao‐Hua Mo, Li Gao, Xiaofei Zhu, et al.
Cancer Cell International (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 64
MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression
Ling Deng, Li Liao, Yinling Zhang, et al.
Cancer Letters (2023) Vol. 560, pp. 216124-216124
Closed Access | Times Cited: 18
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing
Francesca Angiolini, Elisa Belloni, Marco Giordano, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 52
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer
Patrick S. Dischinger, Elizabeth A. Tovar, Curt J. Essenburg, et al.
npj Breast Cancer (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 51
LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma
Fuyang Chen, Mingyue Liu, Yixiu Yu, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 9, pp. 1270-1280
Open Access | Times Cited: 49
OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine
Andrés López‐Cortés, César Paz‐y‐Miño, Santiago Guerrero, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 42
CRISPR-based genome editing to endogenously distinguish the paralogs MAGOH and MAGOHB
Ayushi Rehman, A. V. Narwade, Kusum Singh
Gene Reports (2025) Vol. 38, pp. 102152-102152
Closed Access
Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
Mari C. Vázquez‐Borrego, Antonio C. Fuentes-Fayos, Eva Venegas‐Moreno, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1439-1439
Open Access | Times Cited: 38
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells
Chiara Naro, Monica De Musso, Francesca Delle Monache, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 28
Splicing dysregulation as a driver of breast cancer
Abigail Read, Rachael Natrajan
Endocrine Related Cancer (2018) Vol. 25, Iss. 9, pp. R467-R478
Open Access | Times Cited: 34
Distinct co-expression networks using multi-omic data reveal novel interventional targets in HPV-positive and negative head-and-neck squamous cell cancer
Raquel L. Costa, Mariana Boroni, Marcelo A. Soares
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
Trishna Pani, Kajal Rajput, Animesh Kar, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 22
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer
Chiara Naro, Federica Barbagallo, Cinzia Caggiano, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
<p>Metastasis inhibition in breast cancer by targeting cancer cell extravasation</p>
Márcia R. Cominetti, Wanessa Fernanda Altei, Heloísa Sobreiro Selistre-de-Araújo
Breast Cancer Targets and Therapy (2019) Vol. Volume 11, pp. 165-178
Open Access | Times Cited: 24
Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis
Ziyue Lin, Rui Peng, Yan Sun, et al.
Bioscience Reports (2020) Vol. 41, Iss. 1
Open Access | Times Cited: 23
Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer
Junyi Li, Tao Pan, Liuxin Chen, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 24, pp. 792-806
Open Access | Times Cited: 20
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
Riccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3822-3822
Open Access | Times Cited: 18
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer
Cinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114751-114751
Open Access | Times Cited: 2
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature
Bartosz Wojtaś, Bartłomiej Gielniewski, Kamil Wojnicki, et al.
Cancers (2019) Vol. 11, Iss. 3, pp. 284-284
Open Access | Times Cited: 21
Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer
Caixia Wang, Mingjun Zheng, Shuang Wang, et al.
BioMed Research International (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 20
Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis
Lifeng Yang, Fan Yang, Fanglin Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 12, pp. 5242-5258
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top